Equities

NanJing Pharmaceutical Co Ltd

600713:SHH

NanJing Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)4.48
  • Today's Change0.03 / 0.67%
  • Shares traded6.24m
  • 1 Year change-15.15%
  • Beta0.9515
Data delayed at least 15 minutes, as of Mar 28 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.

  • Revenue in CNY (TTM)53.33bn
  • Net income in CNY565.72m
  • Incorporated1994
  • Employees5.06k
  • Location
    NanJing Pharmaceutical Co LtdBuilding 8(Nanjng Intrntnl Hlth Indl Prk,No.1 YjXiaoxingli, Yuhuatai DistrictNANJING 210012ChinaCHN
  • Phone+86 2 584552601
  • Fax+86 2 584552601
  • Websitehttps://www.njyy.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai New World Co Ltd1.08bn31.68m3.95bn1.23k124.590.9307--3.670.0490.0491.666.550.18864.137.45873,336.100.55921.320.7431.8034.6732.052.975.351.43--0.121448.81-27.07-22.41-174.90--35.37-32.24
NanJing Pharmaceutical Co Ltd53.33bn565.72m5.83bn5.06k10.230.914--0.10930.4350.43541.024.871.669.243.3910,544,120.002.162.248.389.346.116.501.301.261.072.930.602330.5011.3011.7617.9120.71-8.919.24
Guangxi LiuYao Group Co Ltd20.45bn800.82m7.62bn5.16k9.521.17--0.37292.212.2156.4417.971.027.661.963,961,076.004.365.3711.4512.6611.2611.684.274.481.266.340.564130.4511.1915.0624.4211.81-0.69238.57
Data as of Mar 28 2024. Currency figures normalised to NanJing Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

2.44%Per cent of shares held by top holders
HolderShares% Held
GF Fund Management Co., Ltd.as of 30 Jun 20236.45m0.62%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20234.83m0.46%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20234.60m0.44%
Lion Fund Management Co., Ltd.as of 30 Jun 20232.51m0.24%
China Fund Management Co., Ltd.as of 30 Jun 20231.98m0.19%
The Vanguard Group, Inc.as of 29 Feb 20241.88m0.18%
Gfund Management Co., Ltd.as of 30 Jun 20231.58m0.15%
Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023959.60k0.09%
China Merchants Fund Management Co., Ltd.as of 30 Jun 2023500.70k0.05%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2023121.00k0.01%
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.